In vitro microvessels for the study of angiogenesis and thrombosis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 24, 2012, Pages 9342-9347

  Zheng, Ying ^a,b,c   Chen, Junmei ^d   Craven, Michael ^c   Choi, Nak Won ^c,f   Totorica, Samuel ^b   Diaz Santana, Anthony ^c   Kermani, Pouneh ^e   Hempstead, Barbara ^e   Fischbach Teschl, Claudia ^c   López, José A ^b,d   Stroock, Abraham D ^c  

^a University of Washington   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Cornell University   (United States)

^d PUGET SOUND BLOOD CENTER   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f Korea Institute of Science and Technology   (South Korea)

Author keywords

Blood; Cancer; Microfluidics; Regenerative medicine; Tissue engineering

Indexed keywords

COLLAGEN; TISSUE SCAFFOLD;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATION; MICROFLUIDIC ANALYSIS; MICROVASCULATURE; PRIORITY JOURNAL; REGENERATIVE MEDICINE; THREE DIMENSIONAL IMAGING; THROMBOSIS; TISSUE ENGINEERING; VASCULAR ENDOTHELIUM;

CELLS, CULTURED; COLLAGEN TYPE I; HUMANS; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; THROMBOSIS;

EID: 84862197029     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1201240109     Document Type: Article

References (51)

1. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70. (Pubitemid 30046295)
2. Battegay EJ (1995) Angiogenesis: Mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med 73:333-346.
3. Moake JL, et al. (1982) Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 307:1432-1435. (Pubitemid 13234018)
4. Griffith LG, Swartz MA(2006) Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 7:211-224.
5. Staton CA, et al. (2004) Current methods for assaying angiogenesis in vitro and in vivo. Int J Exp Pathol 85:233-248. (Pubitemid 39319155)
6. Naito Y, et al. (2011) Vascular tissue engineering: Toward the next generation vascular grafts. Adv Drug Deliv Rev 63:312-323.
7. Chrobak KM, Potter DR, Tien J (2006) Formation of perfused, functional microvascular tubes in vitro. Microvasc Res 71:185-196. (Pubitemid 43794856)
8. Koike N, et al. (2004) Creation of long-lasting blood vessels. Nature 428:138-139. (Pubitemid 38374298)
9. Choi NW, et al. (2007) Microfluidic scaffolds for tissue engineering. Nat Mater 6:908-915. (Pubitemid 350050588)
10. Harley BAC, et al. (2008) Microarchitecture of 3D scaffolds influences cell migration behavior via junction interactions. Biophys J 95:4013-4024.
11. Golden AP, Tien J (2007) Fabrication of microfluidic hydrogels using molded gelatin as a sacrificial element. Lab Chip 7:720-725. (Pubitemid 46848690)
12. Wong KHK, Truslow JG, Tien J (2010) The role of cyclic AMP in normalizing the function of engineered human blood microvessels in microfluidic collagen gels. Biomaterials 31:4706-4714.
13. Price GM, et al. (2010) Effect of mechanical factors on the function of engineered human blood microvessels in microfluidic collagen gels. Biomaterials 31:6182-6189.
14. Ayalon O, Sabanai H, Lampugnani MG, Dejana E, Geiger B (1994) Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells. J Cell Biol 126:247-258.
15. Dejana E (1996) Endothelial adherens junctions: Implications in the control of vascular permeability and angiogenesis. J Clin Invest 98:1949-1953.
16. Cross VL, et al. (2010) Dense collagen matrices with microstructure and cellular remodeling for three-dimensional cell culture. Biomaterials 31:8596-8607.
17. Caplan BA, Gerrity RG, Schwartz CJ (1974) Endothelial cell morphology in focal areas of in vivo Evans blue uptake in young pig aorta. 1. Quantitative light microscopic findings. Exp Mol Pathol 21:102-117.
18. Chiu JJ, Wang DL, Chien S, Skalak R, Usami S (1998) Effects of disturbed flow on endothelial cells. J Biomech Eng 120:2-8. (Pubitemid 28110431)
19. Ogawa K, Imai M, Ogawa T, Tsukamoto Y, Sasaki F (2001) Caveolar and intercellular channels provide major transport pathways of macromolecules across vascular endothelial cells. Anat Rec 264:32-42. (Pubitemid 32800520)
20. Gerrity RG, Richardson M, Somer JB, Bell FP, Schwartz CJ (1977) Endothelial cell morphology in areas of in vivo Evans blue uptake in aorta of young pigs. 2. Ultrastructure of intima in areas of differing permeability of proteins. Am J Pathol 89:313-335.
21. YuanW, Lv Y, Zeng M, Fu BM (2009) Non-invasive measurement of solute permeability in cerebral microvessels of the rat. Microvasc Res 77:166-173.
22. Wu MH, Ustinova E, Granger HJ (2001) Integrin binding to fibronectin and vitronectin maintains the barrier function of isolated porcine coronary venules. J Physiol 532:785-791. (Pubitemid 32427891)
23. Mehta D, Malik AB (2006) Signaling mechanisms regulating endothelial permeability. Physiol Rev 86:279-367.
24. Bayless KJ, Davis GE (2003) Sphingosine-1-phosphate markedly induces matrix metalloproteinase and integrin-dependent human endothelial cell invasion and lumen formation in 3D collagen and fibrin matrices. Biochem Biophys Res Commun 312:903-913. (Pubitemid 37490902)
25. Song JW, Munn LL (2011) Fluid forces control endothelial sprouting. Proc Natl Acad Sci USA 108:15342-15347.
26. Roukens MG, et al. (2010) Control of endothelial sprouting by a Tel-CtBP complex. Nat Cell Biol 12:933-942.
27. Vailhe B, Vittet D, Feige JJ (2001) In vitro models of vasculogenesis and angiogenesis. Lab Invest 81:439-452. (Pubitemid 32298789)
28. McDonald DM, Baluk P (2002) Significance of blood vessel leakiness in cancer. Cancer Res 62:5381-5385. (Pubitemid 35024617)
29. Stratman AN, Malotte KM, Mahan RD, Davis MJ, Davis GE (2009) Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 114:5091-5101.
30. Dore-Duffy P, Katychev A, Wang XQ, Van Buren E (2006) CNS microvascular pericytes exhibit multipotential stem cell activity. J Cereb Blood Flow Metab 26:613-624.
31. Williams BR, Gelman RA, Poppke DC, Piez KA (1978) Collagen fibril formation - optimal in vitro conditions and preliminary kinetic results. J Biol Chem 253:6578-6585. (Pubitemid 9030256)
32. Greenberg JI, et al. (2008) A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 456:809-U101.
33. Wagner DD, Frenette PS (2008) The vessel wall and its interactions. Blood 111:5271-5281.
34. Dong JF, et al. (2002) ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 100:4033-4039.
35. Huang J, Roth R, Heuser JE, Sadler JE (2009) Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress. Blood 113:1589-1597.
36. Rosenblum WI, et al. (1996) Role of platelet-endothelial cell adhesion molecule (PECAM) in platelet adhesion aggregation over injured but not denuded endothelium in vivo and ex vivo. Stroke 27:709-711. (Pubitemid 26114438)
37. Ruggeri ZM, Mendolicchio GL (2007) Adhesion mechanisms in platelet function. Circ Res 100:1673-1685. (Pubitemid 46987859)
38. Ruggeri ZM, Orje JN, Habermann R, Federici AB, Reininger AJ (2006) Activation-independent platelet adhesion and aggregation under elevated shear stress. Blood 108:1903-1910. (Pubitemid 44394999)
39. Lopez JA, Chen JM (2009) Pathophysiology of venous thrombosis. Thromb Res 123:S30-S34.
40. Motto DG, et al. (2005) Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice. J Clin Invest 115:2752-2761. (Pubitemid 41434402)
41. Wu W, DeConinck A, Lewis JA (2011) Omnidirectional printing of 3D microvascular networks. Adv Mater 23:H178-H183.
42. Nelson CM, Bissell MJ (2006) Of extracellular matrix, scaffolds, and signaling: Tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol 22:287-309.
43. Culver JC, Dickinson ME (2010) The effects of hemodynamic force on embryonic development. Microcirculation 17:164-178.
44. Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD (2006) Blood-brain barrier: Structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 1:223-236. (Pubitemid 44244128)
45. Stroock AD, Fischbach C (2010) Microfluidic culture models of tumor angiogenesis. Tissue Eng Part A 16:2143-2146.
46. Yamagishi S, Imaizumi T (2005) Diabetic vascular complications: Pathophysiology, biochemical basis and potential therapeutic strategy. Curr Pharm Des 11:2279-2299. (Pubitemid 40872698)
47. Ferrara N, Hillan KJ, NovotnyW(2005) Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem Biophys Res Commun 333:328-335. (Pubitemid 40848295)
48. McLaughlin VV, et al. (2003) Efficacy and safety of treprostinil: An epoprostenol analog for primary pulmonary hypertension. J Cardiovasc Pharmacol 41:293-299. (Pubitemid 36135255)
49. Bunn HF (1997) Mechanisms of disease - pathogenesis and treatment of sickle cell disease. N Engl J Med 337:762-769.
50. Chen J, et al. (2011) N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice. J Clin Invest 121:593-603.
51. Levenberg S, et al. (2005) Engineering vascularized skeletal muscle tissue. Nat Biotechnol 23:879-884. (Pubitemid 43093132)